Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


ucin1214234148.pdf (1.91 MB)

ETD Abstract Container

Abstract Header

In vitro Characterization of Echogenic Liposomes (ELIP) for Ultrasonic Delivery of Recombinant Tissue-type Plasminogen Activator (rt-PA)

SMITH, DENISE ANNE BUSH
http://rave.ohiolink.edu/etdc/view?acc_num=ucin1214234148

Abstract Details

2008, PhD, University of Cincinnati, Engineering : Biomedical Engineering.
Ultrasound contrast agents (UCAs) stabilized against gas diffusion in the bloodstream yet triggered for destruction by specially designed pulses of ultrasound are desirable for clinical applications in vivo. Echogenic liposomes (ELIP) are nano-sized phospholipid vesicles that contain both gas and fluid. With incorporation of a drug, such as recombinant tissue-Plasminogen Activator (rt-PA), these liposomes may be able to deliver a high local concentration of rt-PA by site-specific delivery of the drug directly to thrombi, with a lower systemic dose overall. Therefore, it is necessary to assess ELIP stability and destruction thresholds in vitro before their application in clinical diagnostic imaging and targeted drug delivery. Several researchers have used optical and acoustic techniques to identify three dominant mechanisms of UCA destruction; static diffusion, acoustically driven diffusion, and fragmentation (Chomas et al, 2001a; Bouakaz et al., 2005; Porter et al., 2006). We have developed new acoustic techniques to assess these three destruction thresholds of an FDA-approved UCA, Optison®, and unmodified ELIP utilizing a clinical diagnostic ultrasound scanner (Porter et al., 2006; Smith et al., 2007a). Recently, in vitro studies were performed with an innovative drug-encapsulated contrast agent, rt-PA-loaded ELIP. Their stability during contrast imaging was assessed using low output B-mode pulses and rt-PA was found to remain associated with the lipid bilayer. They were also fragmented using color Doppler pulses for determination of drug delivery by spectrophotometrically measuring the concentration of rt-PA released (Smith et al., 2007b). The primary objective of this dissertation was to characterize a novel echogenic lipid-based drug-encapsulated UCA using a diagnostic ultrasound scanner for its potential use in both image-guided and ultrasound-triggered drug delivery.
Christy K. Holland, PhD (Committee Chair)
William S. Ball, MD (Committee Member)
George J. Shaw, MD, PhD (Committee Member)
T. Douglas Mast, PhD (Committee Member)
194 p.
Acoustics; Biomedical Research; Engineering; Health; Pharmaceuticals; Physics; Radiology; Scientific Imaging
echogenic liposomes; ultrasound; diagnostic ultrasound; Optison; contrast agents; ultrasound-enhanced thrombolysis; rt-PA; drug delivery; drug release; destruction threshold; static diffusion; acoustically driven diffusion; rapid fragmentation

Recommended Citations

Citations

  • SMITH, D. A. B. (2008). In vitro Characterization of Echogenic Liposomes (ELIP) for Ultrasonic Delivery of Recombinant Tissue-type Plasminogen Activator (rt-PA) [Doctoral dissertation, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1214234148

    APA Style (7th edition)

  • SMITH, DENISE. In vitro Characterization of Echogenic Liposomes (ELIP) for Ultrasonic Delivery of Recombinant Tissue-type Plasminogen Activator (rt-PA). 2008. University of Cincinnati, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1214234148.

    MLA Style (8th edition)

  • SMITH, DENISE. "In vitro Characterization of Echogenic Liposomes (ELIP) for Ultrasonic Delivery of Recombinant Tissue-type Plasminogen Activator (rt-PA)." Doctoral dissertation, University of Cincinnati, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1214234148

    Chicago Manual of Style (17th edition)

ucin1214234148
769
© 2008, all rights reserved.
This open access ETD is published by University of Cincinnati and OhioLINK.